Search Results - "Jennifer A. Sandberg"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    The encapsulation of ribozymes in biodegradable polymeric matrices by Jackson, John K, Liang, Linda S, Hunter, William L, Reynolds, Mark, Sandberg, Jennifer A, Springate, Chris, Burt, Helen M

    Published in International journal of pharmaceutics (28-08-2002)
    “…Ribozymes are catalytic RNA that bind and cleave specific regions of target RNA. Therefore, protein synthesis by the target RNA may be specifically inhibited…”
    Get full text
    Journal Article
  2. 2

    Pharmacokinetics and Tolerability of an Antiangiogenic Ribozyme (ANGIOZYME™) in Healthy Volunteers by Sandberg, Jennifer A., Parker, Vann P., Blanchard, Karin S., Sweedler, David, Powell, James A., Kachensky, Arlee, Bellon, Laurent, Usman, Nassim, Rossing, Thomas, Borden, Ernest, Blatt, Lawrence M.

    Published in Journal of clinical pharmacology (01-12-2000)
    “…The pharmacokinetics and tolerability of a chemically stabilized synthetic ribozyme (ANGIOZYME™) targeting the Flt‐1 VEGF receptor mRNA were evaluated in…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Quantitative exposure assessment: application of physiologically-based pharmacokinetic (PBPK) modeling of low-dose, long-term exposures of organic acid toxicant in the brain by Kim, Chung S, Sandberg, Jennifer A, Slikker, William, Binienda, Zbigniew, Schlosser, Paul M, Patterson, Tucker A

    Published in Environmental toxicology and pharmacology (01-03-2001)
    “…Our objective was to construct a physiologically-based pharmacokinetic (PBPK) model describing the kinetic behavior of 2,4-dichlorophenoxyacetic acid (2,4-D)…”
    Get full text
    Journal Article
  4. 4

    Temporal development of 2′,3′-dideoxyinosine (ddI)–induced peripheral myelinopathy by Patterson, Tucker A, Schmued, Larry C, Sandberg, Jennifer A, Slikker, William

    Published in Neurotoxicology and teratology (01-05-2000)
    “…The anti-HIV therapeutic dideoxyinosine (ddI) has been reported to produce a painful, dose-limiting peripheral myelinopathy in HIV-infected patients after…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Transplacental Pharmacokinetics and Fetal Distribution of Azidothymidine, Its Glucuronide, and Phosphorylated Metabolites in Late-Term Rhesus Macaques after Maternal Infusion by Tucker A. Patterson, Zbigniew K. Binienda, George W. Lipe, Michael P. Gillam, William Slikker, Jr, Jennifer A. Sandberg

    Published in Drug metabolism and disposition (01-04-1997)
    “…3′-Azido-3′-deoxythymidine (AZT) is currently prescribed to pregnant women infected with human immunodeficiency virus to reduce the risk of vertical…”
    Get full text
    Journal Article
  7. 7

    Quantitative low-dose assessment of seafood toxin, domoic acid, in the rat brain: application of physiologically-based pharmacokinetic (PBPK) modeling by Kim, Chung S, Ross, Ivan A, Sandberg, Jennifer A, Preston, Edward

    Published in Environmental toxicology and pharmacology (04-08-1998)
    “…The purpose of this study was to construct a physiologically based pharmacokinetic model and demonstrate its ability to predict low-dose uptake of domoic acid,…”
    Get full text
    Journal Article
  8. 8

    Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in Mice by Lee, Patrice A., Blatt, Lawrence M., Blanchard, Karin S., Bouhana, Karyn S., Pavco, Pamela A., Bellon, Laurent, Sandberg, Jennifer A.

    Published in Hepatology (Baltimore, Md.) (01-09-2000)
    “…A nuclease resistant ribozyme targeting the 5′ untranslated region (5′ UTR) of hepatitis C virus (HCV) at site 195 has been identified. To investigate the…”
    Get full text
    Journal Article
  9. 9

    Transplacental pharmacokinetics and fetal distribution of 2′,3′-didehydro-3′-deoxythymidine (d4T) and its metabolites in late-term rhesus macaques by Patterson, Tucker A., Binienda, Zbigniew K., Newport, Glenn D., Lipe, George W., Gillam, Michael P., Slikker Jr, William, Sandberg, Jennifer A.

    Published in Teratology (Philadelphia) (01-08-2000)
    “…Background The overall goal of human immunodeficiency virus (HIV) therapy during pregnancy is to maintain maternal health and reduce the probability of…”
    Get full text
    Journal Article
  10. 10

    Quantitative Determination of a Chemically Modified Hammerhead Ribozyme in Blood Plasma Using 96-Well Solid-Phase Extraction Coupled with High-Performance Liquid Chromatography or Capillary Gel Electrophoresis by Bellon, Laurent, Maloney, Lara, Zinnen, Shawn P., Sandberg, Jennifer A., Johnson, Kevin E.

    Published in Analytical biochemistry (01-08-2000)
    “…Versatile bioanalytical assays to detect chemically stabilized hammerhead ribozyme and putative ribozyme metabolites from plasma are described. The extraction…”
    Get full text
    Journal Article
  11. 11

    Developmental pharmacology and toxicology of anti-HIV therapeutic agents: dideoxynucleosides by Sandberg, J A, Slikker, Jr, W

    Published in The FASEB journal (01-09-1995)
    “…As the incidence of human immunodeficiency virus (HIV) infection has increased in women over the past decade, the need for safe, effective therapy during…”
    Get more information
    Journal Article
  12. 12

    Effects of fumonisin B1 treatment on blood-brain barrier transfer in developing rats by Kwon, Oh-Seung, Sandberg, Jennifer A., Slikker, William

    Published in Neurotoxicology and teratology (01-03-1997)
    “…Fumonisin B1 (FB1), a toxic metabolite of the fungus Fusarium moniliforme found in contaminated corn, is considered an etiologic agent of equine…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Evaluation of brain and nerve pathology in rats chronically dosed with ddI or isoniazid by Schmued, Larry C., Albertson, Christopher M., Andrews, Annette, Sandberg, Jennifer A., Nickols, Jess, Slikker, William

    Published in Neurotoxicology and teratology (01-09-1996)
    “…The antiviral adenosine analog, 2′,3′-dideoxyinosine (ddI), and the antitubercular nicotinic acid analogue, isoniazid, have recently received widespread…”
    Get full text
    Journal Article
  15. 15

    Distribution of 2,4-dichlorophenoxyacetic acid (2,4-D) in maternal and fetal rabbits by Sandberg, J A, Duhart, H M, Lipe, G, Binienda, Z, Slikker, Jr, W, Kim, C S

    “…The distribution of 2,4-dichlorophenoxyacetic acid (2,4-D) was examined in maternal and fetal rabbits. Pregnant New Zealand rabbits (28-30 d gestational age)…”
    Get more information
    Journal Article
  16. 16

    Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse by Sandberg, J A, Bouhana, K S, Gallegos, A M, Agrawal, A B, Grimm, S L, Wincott, F E, Reynolds, M A, Pavco, P A, Parry, T J

    Published in Antisense & nucleic acid drug development (01-06-1999)
    “…Vascular endothelial growth factor (VEGF) is a growth factor that contributes to the angiogenesis of developing tumors. To interfere with the action of VEGF, a…”
    Get more information
    Journal Article
  17. 17

    Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkey by Sandberg, J A, Sproul, C D, Blanchard, K S, Bellon, L, Sweedler, D, Powell, J A, Caputo, F A, Kornbrust, D J, Parker, V P, Parry, T J, Blatt, L M

    Published in Antisense & nucleic acid drug development (01-06-2000)
    “…The potential acute toxicity of a ribozyme (ANGIOZYME) targeting the flt-1 vascular endothelial growth factor (VEGF) receptor mRNA was evaluated in cynomolgus…”
    Get more information
    Journal Article